Company
United StatesPublic company, NASDAQ: AXSMAxsome Therapeutics, Inc. (NASDAQ: AXSM), New York, NY – FDA Inspections
Inspection records and compliance data for Axsome Therapeutics, Inc. in New York, New York. 2 FDA inspections on record, 1 Form 483, last inspected February 06, 2026. Publicly traded as NASDAQ: AXSM.
Company Profile
This profile covers Axsome Therapeutics, Inc. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected July 1, 2021. Last inspected February 6, 2026.
Most cited issue areas
- General responsibilities of sponsors1 inspection
- Notification of FDA of termination of investigator1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 6, 2026 | VAI | Human Drugs · Bioresearch Monitoring: Human Drugs | 1301534 |
| July 1, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1146168 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Axsome Therapeutics, Inc.
Stock ticker
AXSM
Exchange
NASDAQ
Share price
$144.37
Market cap
$7.6B
Price as of
November 13, 2026
FEI Number
3018815311
Address
22 Cortlandt St Fl 16, New York, New York 10007, United States
Country
United States
ID: 0bc3d1e2-dfe0-47ba-b144-4248f1fdfdf0